
Jeffrey P. Mornhinweg
Examiner (ID: 16856, Phone: (571)270-5272 , Office: P/1793 )
| Most Active Art Unit | 1793 |
| Art Unit(s) | 1793, 1789 |
| Total Applications | 631 |
| Issued Applications | 204 |
| Pending Applications | 106 |
| Abandoned Applications | 354 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19164780
[patent_doc_number] => 11980662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Influenza virus vectors and uses therefor
[patent_app_type] => utility
[patent_app_number] => 17/675297
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 79
[patent_no_of_words] => 38974
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675297 | Influenza virus vectors and uses therefor | Feb 17, 2022 | Issued |
Array
(
[id] => 19061223
[patent_doc_number] => 11940449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Specific antigen sequences for COVID-19 and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/669979
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10771
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669979 | Specific antigen sequences for COVID-19 and methods of use | Feb 10, 2022 | Issued |
Array
(
[id] => 19135778
[patent_doc_number] => 11970709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Adenoviral vector
[patent_app_type] => utility
[patent_app_number] => 17/587376
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 16152
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587376 | Adenoviral vector | Jan 27, 2022 | Issued |
Array
(
[id] => 18732565
[patent_doc_number] => 11801285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Methods and compositions for treating coronavirus infections
[patent_app_type] => utility
[patent_app_number] => 17/585022
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 19004
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585022 | Methods and compositions for treating coronavirus infections | Jan 25, 2022 | Issued |
Array
(
[id] => 18955618
[patent_doc_number] => 20240043945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2
[patent_app_type] => utility
[patent_app_number] => 18/275540
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275540 | CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2 | Jan 23, 2022 | Pending |
Array
(
[id] => 17805914
[patent_doc_number] => 20220257749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/583088
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 125644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583088 | Influenza virus hemagglutinin proteins and uses thereof | Jan 23, 2022 | Issued |
Array
(
[id] => 18955618
[patent_doc_number] => 20240043945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2
[patent_app_type] => utility
[patent_app_number] => 18/275540
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/275540 | CATALYTIC AMPLIFICATION BY TRANSITION-STATE MOLECULAR SWITCHES FOR DIRECT AND SENSITIVE DETECTION OF SARS-COV-2 | Jan 23, 2022 | Pending |
Array
(
[id] => 17775047
[patent_doc_number] => 20220241396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => MUTATIONS THAT CONFER GENETIC STABILITY TO GENES IN INFLUENZA VIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/578939
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 460
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578939 | MUTATIONS THAT CONFER GENETIC STABILITY TO GENES IN INFLUENZA VIRUSES | Jan 18, 2022 | Abandoned |
Array
(
[id] => 17960404
[patent_doc_number] => 20220340984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/576974
[patent_app_country] => US
[patent_app_date] => 2022-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576974 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM | Jan 15, 2022 | Pending |
Array
(
[id] => 17960404
[patent_doc_number] => 20220340984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/576974
[patent_app_country] => US
[patent_app_date] => 2022-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576974 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM | Jan 15, 2022 | Pending |
Array
(
[id] => 17760070
[patent_doc_number] => 20220233682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 17/573806
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573806 | VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS | Jan 11, 2022 | Abandoned |
Array
(
[id] => 19374157
[patent_doc_number] => 12065707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Compositions, kits and methods for detection of viral sequences
[patent_app_type] => utility
[patent_app_number] => 17/567411
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 36648
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/567411 | Compositions, kits and methods for detection of viral sequences | Jan 2, 2022 | Issued |
Array
(
[id] => 18988178
[patent_doc_number] => 20240060147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => PATHOGEN DETECTION IN LIQUID MATRIX
[patent_app_type] => utility
[patent_app_number] => 18/260181
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260181 | PATHOGEN DETECTION IN LIQUID MATRIX | Dec 29, 2021 | Pending |
Array
(
[id] => 18988178
[patent_doc_number] => 20240060147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => PATHOGEN DETECTION IN LIQUID MATRIX
[patent_app_type] => utility
[patent_app_number] => 18/260181
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260181 | PATHOGEN DETECTION IN LIQUID MATRIX | Dec 29, 2021 | Pending |
Array
(
[id] => 18932531
[patent_doc_number] => 11884939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Vaccinia virus mutants useful for cancer immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/565332
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 99
[patent_no_of_words] => 31190
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565332
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565332 | Vaccinia virus mutants useful for cancer immunotherapy | Dec 28, 2021 | Issued |
Array
(
[id] => 17532424
[patent_doc_number] => 20220111033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Methods and Compositions for Heterologous repRNA Immunizations
[patent_app_type] => utility
[patent_app_number] => 17/645556
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/645556 | Methods and compositions for heterologous repRNA immunizations | Dec 21, 2021 | Issued |
Array
(
[id] => 18590255
[patent_doc_number] => 11739138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Compositions and methods for identifying and sorting antigen-specific B cells
[patent_app_type] => utility
[patent_app_number] => 17/557180
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 20
[patent_no_of_words] => 10786
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557180
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557180 | Compositions and methods for identifying and sorting antigen-specific B cells | Dec 20, 2021 | Issued |
Array
(
[id] => 18085778
[patent_doc_number] => 11535900
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-12-27
[patent_title] => Methods and systems for analysis of samples containing particles used for gene delivery
[patent_app_type] => utility
[patent_app_number] => 17/554830
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 17585
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554830 | Methods and systems for analysis of samples containing particles used for gene delivery | Dec 16, 2021 | Issued |
Array
(
[id] => 18986468
[patent_doc_number] => 20240058437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => IMMUNOGENIC PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/267241
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267241 | IMMUNOGENIC PEPTIDE | Dec 16, 2021 | Pending |
Array
(
[id] => 19112780
[patent_doc_number] => 20240124530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => RNA CONSTRUCT
[patent_app_type] => utility
[patent_app_number] => 18/257698
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257698
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257698 | RNA CONSTRUCT | Dec 16, 2021 | Pending |